Infiltration of tumor-associated macrophages is involved in CD44 expression in clear cell renal cell carcinoma

Cancer Science

Volumn 107, Issue 5, 2016, Pages 700-707

  Ma, Chaoya ^a   Komohara, Yoshihiro ^a   Ohnishi, Koji ^a   Shimoji, Tetsu ^a   Kuwahara, Nao ^a   Sakumura, Yasuo ^a   Matsuishi, Kozue ^a   Fujiwara, Yukio ^a   Motoshima, Takanobu ^a   Takahashi, Wataru ^a   Yamada, Sohsuke ^b   Kitada, Shohei ^b   Fujimoto, Naohiro ^b   Nakayama, Toshiyuki ^b   Eto, Masatoshi ^a,c   Takeya, Motohiro ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

RCC; TAM; CD163; CD44; Macrophage

Indexed keywords

ANTIBODY; CD163 ANTIGEN; CD204 ANTIBODY; HERMES ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR MARKER; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD44 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CANCER STEM CELL; CANCER SURVIVAL; CELL INFILTRATION; COCULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY CARCINOMA; MACROPHAGE CULTURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING; CELL CULTURE; CELL MOTION; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; KIDNEY TUMOR; MACROPHAGE; MALE; METABOLISM; PATHOLOGY;

ANTIGENS, CD44; CARCINOMA, RENAL CELL; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KIDNEY NEOPLASMS; MACROPHAGES; MALE; NF-KAPPA B; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84963860862     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12917     Document Type: Article

References (33)

1. Bukowski RM. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer 1997; 80: 1198-220.
2. Park YH, Baik KD, Lee YJ, Ku JH, Kim HH, Kwak C. Late recurrence of renal cell carcinoma >5 years after surgery: clinicopathological characteristics and prognosis. BJU Int 2012; 110: E553-8.
3. Kim SP, Weight CJ, Leibovich BC et al. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma. Urology 2011; 78: 1101-6.
4. Motzer RJ, Hutson TE, Tomczak P et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol 2009; 27: 3584-90.
5. Xie W, Ren B. Developmental biology. Enhancing pluripotency and lineage specification. Science 2013; 341: 245-7.
6. Garg N, Vijayakumar T, Bakhshinyan D, Venugopal C, Singh SK. MicroRNA regulation of brain tumour initiating cells in central nervous system tumours. Stem Cells Int 2015; 2015: 141793.
7. Yoshida GJ, Saya H. Therapeutic strategies targeting cancer stem cells. Cancer Sci 2016; 107: 5-11.
8. Nagano O, Okazaki S, Saya H. Redox regulation in stem-like cancer cells by CD44 variant isoforms. Oncogene 2013; 32: 5191-8.
9. Shimada Y, Ishii G, Nagai K et al. Expression of podoplanin, CD44, and p63 in squamous cell carcinoma of the lung. Cancer Sci 2009; 100: 2054-9.
10. Zhang Y, Sun B, Zhao X et al. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma. J Surg Oncol 2013; 108: 414-9.
11. Jeong BJ, Liang ZL, Huang SM, Lim JS, Kim JM, Lee HJ. CD44 is associated with tumor recurrence and is an independent poor prognostic factor for patients with localized clear cell renal cell carcinoma after nephrectomy. Exp Ther Med 2012; 3: 811-7.
12. Rioux-Leclercq N, Epstein JI, Bansard JY et al. Clinical significance of cell proliferation, microvessel density, and CD44 adhesion molecule expression in renal cell carcinoma. Hum Pathol 2001; 32: 1209-15.
13. Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci 2004; 95: 930-5.
14. Yu G, Li H, Wang J et al. miRNA-34a suppresses cell proliferation and metastasis by targeting CD44 in human renal carcinoma cells. J Urol 2014; 192: 1229-37.
15. Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9: 239-52.
16. Komohara Y, Hasita H, Ohnishi K et al. Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci 2011; 102: 1424-31.
17. Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. Cancer Sci 2014; 105: 1-8.
18. Kitada S, Yamada S, Kuma A et al. Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas. Br J Cancer 2013; 109: 472-81.
19. Komohara Y, Niino D, Saito Y et al. Clinical significance of CD163 tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma. Cancer Sci 2013; 104: 945-91.
20. Pasparakis M. Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases. Nat Rev Immunol 2009; 9: 778-88.
21. Mikami S, Mizuno R, Kosaka T, Saya H, Oya M, Okada Y. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas. Int J Cancer 2015; 136: 1504-14.
22. Hagemann T, Wilson J, Burke F et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006; 176: 5023-32.
23. Urakawa N, Utsunomiya S, Nishio M et al. GDF15 derived from both tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression via Akt and Erk pathways. Lab Invest 2015; 95: 491-503.
24. Komohara Y, Horlad H, Ohnishi K et al. Importance of direct macrophage-tumor cell interaction on progression of human glioma. Cancer Sci 2012; 103: 2165-72.
25. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009; 9: 361-71.
26. Chittezhath M, Dhillon MK, Lim JY et al. Molecular profiling reveals a tumor-promoting phenotype of monocytes and macrophages in human cancer progression. Immunity 2014; 41: 815-29.
27. Harrison ML, Obermueller E, Maisey NR et al. Tumor necrosis factor alpha as a new target for renal cell carcinoma: two sequential phase II trials of infliximab at standard and high dose. J Clin Oncol 2007; 29: 4542-9.
28. Oshima H, Ishikawa T, Yoshida GJ et al. TNF-α/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells. Oncogene 2014; 33: 3820-9.
29. Roessler K, Suchanek G, Breitschopf H et al. Detection of tumor necrosis factor-alpha protein and messenger RNA in human glial brain tumors: comparison of immunohistochemistry with in situ hybridization using molecular probes. J Neurosurg 1995; 83: 291-7.
30. Bhat KP, Balasubramaniyan V, Vaillant B et al. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma. Cancer Cell 2013; 24: 331-46.
31. Rustom A, Saffrich R, Markovic I, Walther P, Gerdes HH. Nanotubular highways for intercellular organelle transport. Science 2004; 303: 1007-10.
32. Hashimoto M, Bhuyan F, Hiyoshi M et al. HIV spreads in macrophages by promoting tunneling nanotube formation. J Immunol 2016; 196: 1832-41.
33. Costa WH, Rocha RM, Cunha IW, Guimaraes GC, Zequi Sde C. Imunohistochemical expression of CD44s in renal cell carcinoma lacks independent prognostic significance. Int Braz J Urol 2012; 38: 456-65.